Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphoma
Cancer Cell  (IF31.743),  Pub Date : 2021-11-04, DOI: 10.1016/j.ccell.2021.10.007
Patrizia Mondello, Stephen M. Ansell

The molecular classification of diffuse large B cell lymphoma has paved the way for precision medicine that targets oncogenic driver pathways and actionable mutations. In this issue of Cancer Cell, Wilson et al. execute a massive genomic analysis in order to identify putative molecular signatures linked to a differential response to ibrutinib plus R-CHOP.